User contributions
Jump to navigation
Jump to search
- 15:56, 5 September 2023 diff hist +77 m Antiemesis →Emetic risk of chemotherapy, immunotherapy, TKIs and other agents
- 20:40, 2 September 2023 diff hist +480 m Neuroendocrine tumor →All lines of therapy Tag: visualeditor-switched
- 20:30, 2 September 2023 diff hist +836 Neuroendocrine tumor capecitabine & temozolomide for NET Tag: visualeditor-switched
- 23:45, 17 June 2021 diff hist +158 m Antiemesis Selinexor added to antiemetic table
- 21:01, 8 June 2021 diff hist +64 m Antiemesis lurbinectedine emetic risk added
- 15:58, 8 June 2021 diff hist +1 m Antiemesis formating
- 15:58, 8 June 2021 diff hist +283 m Antiemesis formating, addting drug indexes
- 15:47, 8 June 2021 diff hist +32 m Antiemesis formating antiemetic page
- 15:44, 8 June 2021 diff hist +91 m Antiemesis formating antiemetic page
- 22:19, 4 June 2021 diff hist +743 m Carcinoma of unknown primary Carboplatin & Paclitaxel 2019 regimen for CUP
- 21:07, 19 May 2021 diff hist -2 m User:Karine Karine bio update Tag: visualeditor
- 20:47, 19 May 2021 diff hist +751 m Urothelial carcinoma TROPHY-U-01 study evidence and reference
- 21:09, 14 May 2021 diff hist +1,298 Paroxysmal nocturnal hemoglobinuria iptacopan Lancet study regimen and reference
- 20:55, 14 May 2021 diff hist +91 m Paroxysmal nocturnal hemoglobinuria investigational agents for PNH Tag: visualeditor
- 20:48, 14 May 2021 diff hist +330 m Iptacopan (Fabhalta) Iptacopan drug index info continued
- 20:43, 14 May 2021 diff hist +962 N Iptacopan (Fabhalta) Iptacopan drug index info
- 20:30, 14 May 2021 diff hist +24 m Drug index iptacopan added to drug index
- 16:33, 14 May 2021 diff hist +453 Non-small cell lung cancer Paz-Ares 2021 new regimen, chemo part
- 16:24, 14 May 2021 diff hist +1,860 Non-small cell lung cancer Paz-Ares 2021 new regimen
- 14:52, 14 May 2021 diff hist 0 m Prostate cancer formating